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The Rho family of small guanosine triphosphatases regulates actin cytoskeleton dynamics that underlie cellular functions such as cell shape changes, migration, and polarity. We found that Smurf1, a HECT domain E3 ubiquitin ligase, regulated cell polarity and protrusive activity and was required to maintain the transformed morphology and motility of a tumor cell. Atypical protein kinase C zeta (PKC), an effector of the Cdc42/Rac1-PAR6 polarity complex, recruited Smurf1 to cellular protrusions, where it controlled the local level of RhoA. Smurf1 thus links the polarity complex to degradation of RhoA in lamellipodia and filopodia to prevent RhoA signaling during dynamic membrane movements.
The Rho family of small guanosine triphosphatases (GTPases) cycle between an active guanosine 5Ј-triphosphate (GTP)-bound and inactive guanosine 5Ј-diphosphate (GDP)-bound state to control cell shape, motility, polarity, and behavior (1) (2) (3) (4) (5) . At the leading edge of motile cells, Cdc42 and Rac1 regulate the actin cytoskeleton to form fingerlike filopodia and sheetlike lamellipodia, respectively, whereas in the cell body RhoA induces assembly of focal adhesions and contractile actin-myosin stress fibers. Active Rho GTPases signal through effector complexes (5, 6) , one of which is the PAR (for partitioning defective) polarity complex (7). PAR6 is a key component of this complex that binds atypical protein kinase C zeta (PKC) (8) (9) (10) , recruits it to active Cdc42 (8-10), and is important for cell transformation (10), polarity (11, 12) , and epithelial tight junctions (9, (13) (14) (15) . One effector pathway of this complex involves GSK-3␤ and APC, which links PAR6 to microtubules and astrocyte polarity (16) ; another, involving Lgl, affects asymmetric cell divisions (17) and polarization of migrating cells (18) . A direct link between the polarity complex and regulation of actin cytoskeleton dynamics has not been defined. Conjugation of polyubiquitin chains to protein targets triggers their degradation and is mediated by E3 enzymes, which include the Smurf family of C2-WW-HECT ubiquitin ligases (19, 20) that regulate transforming growth factor-␤ (TGF-␤) signal transduction (21-23). Ubiquitin ligases are not known to regulate cell shape, motility, and polarity. 1A) . Furthermore, movement of YFP-Smurf1 to the tips of processes often preceded active extension (Fig. 1A) , whereas movement to the cell body presaged retraction (Movie S1). Smurf1 expression also strongly reduced stress fiber formation (Movie S1). In contrast, Smurf2 rarely induced protrusive activity (15% of Smurf2-expressing cells). Next, we examined how increased expression of Smurf1 affected the behavior of NIH3T3 fibroblasts in a wounding assay in which cells are induced to polarize and migrate into a wound that is created by scratching the monolayer with a pipette tip. In controls, the leading-edge cells displayed organized migration ( fig. S1 ), whereas Smurf1-expressing cells were highly disorganized and extended more protrusions at the leading edge (2.4 protrusions per cell in Smurf1-expressing populations versus 1.3 in the controls) (Fig.   1B ). This suggested that Smurf1 disrupted polarity, which we examined directly by analyzing the localization of pericentrin, a component of the microtubule organization center (MTOC) (25) (fig. S1 ). In controls, 76 Ϯ 8% of cells at the wound edge exhibited polarized MTOC localization, compared with 30 Ϯ 6% in wild-type Smurf1-expressing cells, indicating nearly random (25%) polarity (Fig.  1B) . In contrast, Smurf1(C699A) had only slight effects on protrusive activity and MTOC polarity. Thus, elevated Smurf1 expression induces protrusive activity and disrupts fibroblast polarity in a manner that is dependent on the catalytic activity of its HECT domain.
To determine the importance of endogenous Smurf1 on protrusive activity, we designed small interfering RNA (siRNA) to Smurf1 that reduced Smurf1 protein by 60% compared with controls ( fig. S2A ). We used the human embryonic kidney (HEK) 293T tumor cell line because these cells are highly transfectable, express Smurf1, extend many cellular protrusions, and display a disorganized actin cytoskeleton typical of a transformed phenotype (Fig. 1C) . Examination of the morphology of Smurf1 siRNAtransfected cells revealed a marked change at 40 hours after transfection. The cells lost their protrusions, the actin cytoskeleton was rearranged into a cortical F-actin staining pattern, and the cells assumed a cuboidal morphology (Fig. 1C) . Similar effects were observed with a second siRNA directed to Smurf1. In addition, HEK293T motility through modified Boyden chambers was reduced sixfold ( fig. S3 ). These data indicate that Smurf1 plays an important role in regulating protrusive activity and the transformed phenotype of HEK293T cells.
Elevated expression of the Rho family GTPases Cdc42 or Rac1 induces high levels of protrusive activity, disrupts polarity, and contributes to cell transformation (26, 27) . Previous studies have established that the PAR6-PKC complex is a key effector of Cdc42 and Rac1 that controls polarity, is localized at lamellipodia and filopodia, and is required for the oncogenic activities of Cdc42 and Rac1 (8) (9) (10) (11) . PKC activity also mediates the loss of stress fibers caused by activated Cdc42 (26) , and in HEK293T cells PKC inhibitors caused morphological changes that were similar to those in Smurf1 siRNA-treated cells (28) . All of this suggested that Smurf1 might function as an effector of this complex. In support of this notion, in Mv1Lu and NIH3T3 cells, Smurf1 was localized to both lamellipodial-and filopodial-like protrusions (Fig. 2, A and B) , where it colocalized extensively with PKC (Fig. 2B) . Furthermore, both the expression of Smurf1 and the kinase activity of PKC were required for the localization of both proteins to membrane protrusions (fig. S4, A and B) . This is consistent with the requirement for atypical PKC activity in the assembly and function of PAR complexes in Caenorhabditis elegans and during tight junction formation in epithelial cells (13, 14, 29, 30) . Next, we demonstrated that endogenous PKC bound Smurf1 and that this was unaffected by treatment with PKC kinase inhibitors (Fig.  2C) . Similar kinase-independent interactions were observed between bacterially produced proteins ( fig. S4C ) and in transiently transfected HEK293T cells, where the steady-state level of PKC was unaffected by Smurf1 ( fig.  S4D ). This indicates that PKC is not a substrate of Smurf1. Thus, PKC binds directly to Smurf1 independent of its kinase activity, but both the expression of Smurf1 and PKC kinase activity are required to localize the complex to filopodia and lamellipodia.
We hypothesized that Smurf1 might be an effector of the Cdc42-PAR6-PKC polarity complex that mediates the ubiquitindependent degradation of RhoA. In support of this, wild-type Smurf1, but neither Smurf2 nor catalytically inactive Smurf1, decreased the steady-state level of RhoA, but had no effect on Cdc42 or Rac1 (Fig. 3A) ; this result was confirmed with the UPR assay (31) (fig.  S5 ). Two proteasome inhibitors, LLnL and lactacystin, reversed this effect (Fig. 3B ) (28) . Furthermore, Smurf1 expression markedly increased ubiquitin-conjugated RhoA, whereas Smurf1(C699A) blocked all detectable ubiquitination of RhoA (Fig. 3C) . Next, we examined RhoA interaction with Smurf1, using catalytically inactive Smurf1 to trap the ligase substrate (21, 32, 33) . Smurf1(C699A) was found to interact with the dominant inactive form of RhoA, RhoA N19 (Fig. 3D ), which binds constitutively to guanine nucleotide exchange factors (GEFs) (34) . Smurf1 also interacted in vitro with either nucleotidefree or GDP-bound RhoA, whereas loading with GTP␥S inhibited the interaction (Fig.  3E) . Because most GDP-bound RhoA in cells is associated with guanine dissociation inhibitor (GDI) (35), these results suggest that GDI may inhibit binding of Smurf1 to GDP-bound RhoA in mammalian cells. Finally, Smurf1 directly catalyzed ubiquitination of RhoA in an in vitro ubiquitination assay (Fig. 3F) . Thus, RhoA is a direct substrate of Smurf1, and degradation of RhoA in mammalian cells may require nucleotide exchange and be dependent on a Rho GEF.
The PKC-dependent recruitment of Smurf1 to active membrane protrusions suggested that at endogenous levels of expression, Smurf1 activity toward RhoA was restricted to sites where the Smurf1-PKC complex assembled with Cdc42-PAR6 to induce membrane protrusions. Consistent with this notion, we did not see marked changes in total RhoA protein levels upon reducing Smurf1 expression (28) . Thus, we considered that the morphological change in HEK293T cells treated with Smurf1 siRNA might be due to ectopic accumulation of RhoA in protrusions. To test this hypothesis, we examined endogenous RhoA localization at 18 hours after Smurf1 siRNA treatment. At this early time point-before morphological changes have occurred-we observed strong accumulations of RhoA and colocalized Factin in the tips of most cellular protrusions. We also observed the initiation of RhoA accumulation at cell-cell junctions (Fig. 4A) . Thus, the maintenance of low local levels of RhoA in protrusions was dependent on endogenous Smurf1. To demonstrate that RhoA degradation was a key target for Smurf1-dependent regulation of the transformed phenotype of HEK293T cells, we next tested the epistatic relation between Smurf1 and RhoA using siRNA. siRNA directed to RhoA blocked expression of the protein ( fig. S2B and Fig. 4B ), but had no effect on the morphology ( fig. S6A ) or F-actin distribution in HEK293T cells (Fig. 4B ). This result indicates that there was little RhoA-dependent regulation of the actin cytoskeleton in these cells, consistent with the absence of a discernible, well-organized stress fiber network. Notably, cotransfection with RhoA siRNA strongly suppressed the effect of Smurf1 siRNA ( fig. S6A and Fig. 4B ). Thus, reducing RhoA expression blocks the morphological transformation and actin cytoskeleton rearrangements caused by reducing Smurf1 levels. We also observed that siRNA to RhoA severely impaired MTOC polarity in NIH3T3 cells ( fig. S6B) , supporting the notion that Smurf1 targeting of RhoA is important for regulating polarity. Our results point to a key role for Smurf1 as an effector of PKC that regulates actin cytoskeleton dynamics during protrusion formation by targeting the localized degradation of RhoA via a ubiquitindependent mechanism.
Regulation of cell polarity and shape by RhoGTPase-dependent regulation of the actin cytoskeleton is a key biological pathway that governs diverse cell functions such as localization of embryonic determinants, establishment of tissue and organ architecture, and cell motility. The precise temporal and spatial coordination of Rho family GTPase activity is important in a broad range of cellular activities (2-5). Our findings strongly suggest that Smurf1 is a key effector of the Cdc42/Rac1-PAR6-PKC pathway that antagonizes RhoA through ubiquitin-dependent degradation. In cells in which Smurf1 expression is knocked down by siRNA, RhoA and associated F-actin accumulate in cellular protrusions, indicating that the activity of Smurf1 toward RhoA is locally restricted to sites of active protrusion. This is likely to be achieved through PKC-dependent recruitment of Smurf1 to filopodia and lamellipodia, which is in agreement with a key role for this kinase in controlling the activity of the polarity complex both in C. elegans (29, 30) and in mammals (13, 14) . Furthermore, we showed that Smurf1 binds RhoA in a GEFdependent manner, suggesting that Smurf1 activity is further restricted by a RhoA GEF that colocalizes with the polarity complex in filopodia and lamellipodia. Localizing the degradation of RhoA to protrusive regions likely acts to prevent inappropriate stress fiber formation during dynamic actin cytoskeletal remodeling that is required to drive rapid filopodial and lamellipodial membrane extensions in response to Cdc42 and Rac1 activation. Moreover, our observation that knocking down Smurf1 expression suppresses the tumorigenic morphology and motility of HEK293T cells suggests that this pathway plays a key role in maintaining the protrusive activity and transformed phenotype of cancer cells.
